ESMO Breast Cancer 2026 Highlights: SERENA-6 - Quiz - MDSpire

ESMO Breast Cancer 2026 Highlights: SERENA-6

Harold Burstein, MD, PhD, and Erica Mayer, MD, MPH discuss results from the SERENA-6 trial, which were presented at the 2026 ESMO Breast Cancer Congress.

June 26, 2026

Dana-Farber

Share

Original Source(s)

Dana-Farber

ESMO Breast Cancer 2026 Highlights: SERENA-6

June 26, 2026

Related Content

Frontiers In Oncology

Comparative effectiveness and safety of adjuvant trastuzumab plus pertuzumab versus trastuzumab emtansine in HER2-positive breast cancer with residual disease after neoadjuvant therapy: a real-world retrospective study

by Zhenghua Liu, Xinyu Wang, Jiayan Gai, Chen Wang, Xinlu Yi, Yufei Liu, Tao Zhou
June 26, 2026

Frontiers In Oncology

Navigating specific targets of psychoneurological symptom cluster in breast cancer: a computer-simulated network analysis

by Jiyu Cai, Zhao Liu, Xianliang Liu, Chunzi Wan, Xia Duan
June 26, 2026

Journal Of Medical Internet Research (Jmir)

Physical Activity Interventions Using Digital Health Interventions for Cancer-Related Fatigue in People With a History of Cancer: Scoping Review

by Yeeun Kim, Ka Ryeong Bae, Ji Hyun Sung, Yun Hee Ko, Sue Kim
June 26, 2026